|

Anxiety and Depression in Patients With Hematologic Malignancies

RECRUITINGSponsored by The First Affiliated Hospital of Xiamen University
Actively Recruiting
SponsorThe First Affiliated Hospital of Xiamen University
Started2026-10-20
Est. completion2030-12-01
Eligibility
Healthy vol.Accepted

Summary

Assessment of Anxiety and Depression Status in Patients with Hematologic Malignancies

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

1. Patients with hematologic malignancies who visit the Department of Hematology at the First Affiliated Hospital of Xiamen University from August 2026 onward, including lymphoma, multiple myeloma, and leukemia.
2. Patients who are able to understand and voluntarily participate in anxiety and depression status assessments.

Exclusion Criteria:

1\. Patients with any other conditions considered by the investigator to be inappropriate for participation in this study.

Conditions4

AnxietyCancerDepressionHematologic Disease

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.